Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
LFMD 
LifeMD Inc (LFMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/11/2025: LFMD (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $12.88
1 Year Target Price $12.88
| 6 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 175.22% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/11/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 282.13M USD | Price to earnings Ratio - | 1Y Target Price 12.88 |
Price to earnings Ratio - | 1Y Target Price 12.88 | ||
Volume (30-day avg) 8 | Beta 1.57 | 52 Weeks Range 3.99 - 15.84 | Updated Date 09/12/2025 |
52 Weeks Range 3.99 - 15.84 | Updated Date 09/12/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.2 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -2.41% | Operating Margin (TTM) -1.46% |
Management Effectiveness
Return on Assets (TTM) -1.85% | Return on Equity (TTM) -2243.07% |
Valuation
Trailing PE - | Forward PE 12.53 | Enterprise Value 265113208 | Price to Sales(TTM) 1.15 |
Enterprise Value 265113208 | Price to Sales(TTM) 1.15 | ||
Enterprise Value to Revenue 1.08 | Enterprise Value to EBITDA 31 | Shares Outstanding 47417400 | Shares Floating 38505768 |
Shares Outstanding 47417400 | Shares Floating 38505768 | ||
Percent Insiders 15.82 | Percent Institutions 53.91 |
Upturn AI SWOT
LifeMD Inc
Company Overview
History and Background
LifeMD Inc. (formerly known as Conversion Labs, Inc.) was founded in 2019. It has evolved from a digital marketing company to a telehealth company focusing on virtual primary care and specialized online healthcare services.
Core Business Areas
- Virtual Primary Care: Offers accessible and affordable healthcare through telehealth, including consultations, prescriptions, and lab tests.
- Men's and Women's Health: Provides personalized treatment plans for various conditions, such as hair loss, sexual health, dermatology, and weight management.
Leadership and Structure
The leadership team includes Justin Schreiber (Chairman and CEO). The company is structured around its different telehealth service offerings.
Top Products and Market Share
Key Offerings
- Rex MD: Offers treatments for erectile dysfunction and other men's health issues. Competitors include Hims & Hers Health (HIMS) and Roman. Market share data is not publicly available, but it's a significant revenue generator. Number of users is not publicly available.
- Nurx: Provides birth control, acne treatment, migraine treatment, and other women's health services. Competitors include Hims & Hers Health (HIMS) and Planned Parenthood. Market share data is not publicly available, but it's a growing segment. Number of users is not publicly available.
- Clearside Health: Virtual Primary Care providing end-to-end healthcare services. Market share data is not publicly available. Competitors include Teladoc Health (TDOC), and Amwell (AMWL). Number of users is not publicly available.
Market Dynamics
Industry Overview
The telehealth market is experiencing significant growth, driven by increased demand for convenient and accessible healthcare services. The market is highly competitive.
Positioning
LifeMD Inc. is positioned as a provider of comprehensive telehealth services, focusing on both general and specialized care. Its competitive advantage lies in its direct-to-consumer marketing and integrated platform.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions USD within the next few years. LifeMD is attempting to capture market share through its diverse services.
Upturn SWOT Analysis
Strengths
- Direct-to-consumer marketing expertise
- Integrated telehealth platform
- Diverse service offerings (men's & women's health)
- Focus on subscription-based revenue
Weaknesses
- High marketing expenses
- Reliance on customer acquisition
- Profitability concerns
- Intense competition in the telehealth space
Opportunities
- Expansion into new telehealth specialties
- Partnerships with healthcare providers and insurers
- Increasing adoption of telehealth services
- Geographic expansion
Threats
- Increased competition from established players
- Changes in telehealth regulations
- Data security and privacy concerns
- Reimbursement challenges
Competitors and Market Share
Key Competitors
- HIMS
- TDOC
- AMWL
Competitive Landscape
LifeMD faces intense competition. Larger companies like Teladoc have a significant advantage in brand recognition and existing partnerships with healthcare providers. LifeMD differentiates through direct-to-consumer focus and specialty services.
Major Acquisitions
Clearside Health
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: To expand into the virtual primary care market.
Growth Trajectory and Initiatives
Historical Growth: LifeMD has experienced rapid revenue growth historically, driven by its marketing efforts and expansion of telehealth services.
Future Projections: Analyst estimates vary, but project continued revenue growth with potential for profitability improvements.
Recent Initiatives: Recent initiatives include expanding its virtual primary care offerings (Clearside Health) and partnerships with other healthcare companies.
Summary
LifeMD is a rapidly growing telehealth company focused on virtual primary care and specialized services, demonstrating revenue growth but facing challenges to profitability. Its direct-to-consumer strategy and diverse offerings are strengths, yet it needs to address high marketing expenses and navigate a competitive market. Expansion into new areas and strategic partnerships are crucial for future success and shareholder return. The company needs to be cognizant of regulatory changes and profitability concerns.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Market Research Reports
- Analyst Reports
- Company Website
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About LifeMD Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2001-01-02 | Chairman & CEO Mr. Justin Schreiber | ||
Sector Healthcare | Industry Health Information Services | Full time employees 304 | Website https://lifemd.com |
Full time employees 304 | Website https://lifemd.com | ||
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.